Artificial General Intelligence has become the technology sector's equivalent of cryogenic immortality—a seductive promise that captivates imaginations and opens wallets, yet remains perpetually just beyond reach. Today's market valuations are not pricing in incremental AI improvements or practical quantum applications. They are pricing in the singularity itself.
The market has made a fatal assumption: that silicon computing or quantum physics will inevitably overcome the human mind. Yet nobody is betting on humans anymore. This collective delusion has created valuation distortions unprecedented in financial history, dwarfing even the dot-com bubble's excesses by orders of magnitude.
Four pure-play quantum computing stocks have become the poster children for AGI-driven speculation, their valuations untethered from any semblance of business fundamentals:
| Company | Ticker | Market Cap | Annual Revenue | P/S Ratio | YTD Gain |
|---|---|---|---|---|---|
| Quantum Computing Inc. | QUBT | $4.8B | $0.26M | 18,550x | +3,150% |
| Rigetti Computing | RGTI | $15.3B | $8.2M | 1,641x | +5,940% |
| IonQ Inc. | IONQ | $25.5B | $52M | 303x | +712% |
| D-Wave Quantum | QBTS | $10.5B | $8.15M | 100x | +345% |
Combined reality check: These four companies command $55.6 billion in market capitalization while generating a collective $68.6 million in annual revenue. Their combined valuation exceeds General Motors ($47B market cap) while producing 0.01% of GM's revenue.
These companies operate at staggering quarterly losses—IonQ lost $176 million, Rigetti burned $39.7 million—with profitability timelines extending into the 2030s under best-case scenarios. Yet investors continue bidding up shares on the thesis that quantum breakthroughs are essential for AGI development.
The market is pricing in not just successful quantum computing, but quantum computing enabling AGI, which itself transforms civilization. This is speculation stacked upon speculation, compounded by magical thinking.
While quantum stocks trade at incomprehensible multiples, pure-play AI companies command equally breathtaking valuations premised on their proximity to AGI:
| Company | Valuation | Annual Revenue | P/S Ratio |
|---|---|---|---|
| OpenAI | $500B | $13B | 38x |
| Anthropic | $183B | $5B | 37x |
| Perplexity AI | $20B | $200M | 100x |
Unlike quantum pure-plays, these companies generate substantial revenue and demonstrate real product-market fit. Yet their valuations embed aggressive assumptions about achieving AGI within investment time horizons—typically 5-10 years. OpenAI's $500 billion valuation, for instance, prices in not just dominance of narrow AI applications, but breakthrough to general intelligence that transforms every industry simultaneously.
While mid-cap and small-cap technology stocks have suffered corrections throughout 2025, the "Magnificent 7" mega-caps have maintained resilience by positioning themselves as AGI infrastructure plays:
| Company | Market Cap | Current P/S | AGI Premium |
|---|---|---|---|
| NVIDIA | $1.2T | 35x | GPU monopoly for AI/AGI training |
| Microsoft | $2.85T | 12x | Azure AI platform + OpenAI partnership |
| Alphabet | $1.9T | 8x | DeepMind AGI research leadership |
| Tesla | $900B | 10x | Dojo supercomputer + FSD AGI ambitions |
| Oracle | $300B | 7x | Autonomous database AI narrative |
These companies have successfully marketed themselves not as mature technology providers, but as essential infrastructure for humanity's inevitable march toward AGI. Their relative outperformance versus smaller tech peers reflects this "AGI premium" embedded in valuations—a premium that evaporates instantly if AGI timelines extend beyond investor patience.
What happens when the market accepts that AGI may remain science fiction for another century? Historical bubble precedents provide sobering guidance:
| Ticker | Current Price | 90% Decline Target | 99% Decline Target |
|---|---|---|---|
| QUBT | $21.78 | $2.18 | $0.22 |
| RGTI | $56.12 | $5.61 | $0.56 |
| IONQ | $77.55 | $7.76 | $0.78 |
| QBTS | $43.06 | $4.31 | $0.43 |
A reversion to "sane" price-to-sales multiples of 10x (generous for pre-revenue companies) implies 90-99.9% declines from current levels. This aligns with dot-com precedent, where speculative names trading at 30-40x sales lost 90-100% of value.
| Company | Current Valuation | 10x P/S Target | Implied Decline |
|---|---|---|---|
| OpenAI | $500B | $130B | -74% |
| Anthropic | $183B | $50B | -73% |
| Perplexity AI | $20B | $2B | -90% |
| Company | Current Market Cap | AGI-Neutral Target | Implied Decline |
|---|---|---|---|
| NVIDIA | $1.2T | $516B | -57% |
| Microsoft | $2.85T | $1.91T | -33% |
| Tesla | $900B | $540B | -40% |
| Alphabet | $1.9T | $1.43T | -25% |
| Oracle | $300B | $213B | -29% |
Recent events have accelerated the AGI bubble rather than puncturing it:
These catalysts have extended the bubble's inflation phase, but they cannot change fundamental mathematics: current valuations require not just technological success, but AGI achievement within 5-10 years. Without that, mathematical reversion is inevitable.
AGI has become the perfect investment narrative—a perpetually "five years away" breakthrough that justifies any valuation today based on hypothetical tomorrow. Like cryogenic immortality or fusion power, it promises transformation without requiring proof.
The AGI narrative succeeds because it's unfalsifiable within investment timeframes. Companies can perpetually claim progress toward AGI without ever delivering it, maintaining premium valuations through narrative management rather than product delivery.
Dot-Com Bubble (2000): NASDAQ fell 78% over 30 months. Companies trading at 30-40x sales lost 90-100%. Current quantum stocks trade at 100-18,550x sales.
Biotech Bubble (1990s-2000s): Pre-revenue biotech firms promising miracle cures collapsed 95-99% when clinical milestones failed. Similar dynamics apply when AGI milestones perpetually slip.
Clean Tech Bubble (2006-2011): Solar and battery companies trading at 20-50x sales fell 80-95% when technological breakthroughs proved slower than projected. AGI faces identical risks.
The no-AGI scenario represents a black swan—not because it's unlikely, but because markets have priced it at near-zero probability. The consensus view holds that AGI is inevitable and imminent. If that consensus cracks, repricing will be violent and indiscriminate.
We stand at a unique moment in financial history where markets have collectively embraced a technological singularity as near-certainty, pricing trillions of dollars on the assumption that human-level machine intelligence is imminent. Yet the fundamental question remains unanswered and perhaps unanswerable: Can silicon or quantum physics truly replicate human consciousness and general intelligence?
If the answer is "not within investment horizons," the withering will be swift and merciless. The no-AGI burst won't announce itself with trumpets—it will arrive quietly, as one quarterly earnings call after another fails to demonstrate meaningful progress toward the promised land.
The bubble will burst not with a bang, but with a collective realization: we've been waiting for Godot, and he's not coming.